Abilify Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
Conditions:   Schizophrenia;   Psychotic Disorders;   Psychosis Interventions:   Drug: Aripiprazole;   Drug: Risperidone Sponsors:   Fundación Marques de Valdecilla;   Centro de Investigación Biomédica en Red de Salud Mental;   Instituto de Investigación Marqués de Valdecilla Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2019 Category: Research Source Type: clinical trials

DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole
Conditions:   Schizophrenia;   Major Depressive Disorder;   Bi-Polar Disorder;   Schizo Affective Disorder Intervention:   Combination Product: ABILIFY MYCITE Sponsors:   Durham VA Medical Center;   Otsuka Pharmaceutical Development and Commercialization, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2019 Category: Research Source Type: clinical trials